Cargando…

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

BACKGROUND: Real-world data on safety and clinical outcomes of remdesivir in COVID-19 management is scant. We present findings of data analysis conducted for assessing the safety and clinical outcomes of remdesivir treatment for COVID-19 in India. METHODS: This retrospective analysis used data from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupte, Vaishali, Hegde, Rashmi, Sawant, Sandesh, Kalathingal, Kabil, Jadhav, Sonali, Malabade, Rohit, Gogtay, Jaideep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724590/ https://www.ncbi.nlm.nih.gov/pubmed/34983406 http://dx.doi.org/10.1186/s12879-021-07004-8

Ejemplares similares

A Questionnaire-based Survey of Physician Perceptions of the Prevalence of Antimicrobial Resistance and Their Antibiotic Prescribing Patterns
por: Gupte, Vaishali, et al.
Publicado: (2018)

Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective
por: Bose, Debdipta, et al.
Publicado: (2021)

Effectiveness and safety of salmeterol/fluticasone fixed-dose combination delivered through Synchrobreathe(®) in patients with asthma: the real-world EVOLVE study
por: Balamurugan, Santhalingam, et al.
Publicado: (2022)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis
por: Angamo, Mulugeta T., et al.
Publicado: (2021)

The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
por: Talwar, Deepak, et al.
Publicado: (2021)

Calotropis procera: A potential cognition enhancer in scopolamine and electroconvulsive shock-induced amnesia in rats
por: Malabade, Rohit, et al.
Publicado: (2015)

The journey of remdesivir: from Ebola to COVID-19
por: Pardo, Joe, et al.
Publicado: (2020)

Lipid management in India: a nationwide, cross-sectional physician survey
por: Wander, Gurpreet S., et al.
Publicado: (2017)

Management of Diabetic Foot in an Indian Clinical Setup: An Opinion Survey
por: Das, Ashok, et al.
Publicado: (2020)

Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised study
por: Salvi, Sundeep, et al.
Publicado: (2022)

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
por: Carta, Andrea, et al.
Publicado: (2021)

Research methodology workshops: A small step towards practice of evidence-based medicine
por: Gogtay, Nithya Jaideep
Publicado: (2018)

Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database
por: Jung, Se Yong, et al.
Publicado: (2021)

Safety profile of the antiviral drug remdesivir: An update
por: Fan, Qianqian, et al.
Publicado: (2020)

Remdesivir; molecular and functional measures of mitochondrial safety
por: Bjork, J.A., et al.
Publicado: (2021)

Summary Safety Review: sinus bradycardia with remdesivir
Publicado: (2021)

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
por: Leegwater, Emiel, et al.
Publicado: (2023)

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Safety of Remdesivir in Patients With Acute Kidney Injury or CKD
por: Thakare, Sayali, et al.
Publicado: (2020)

Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
por: Humeniuk, Rita, et al.
Publicado: (2023)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

Planning for COVID-19 vaccines safety surveillance
por: Kochhar, Sonali, et al.
Publicado: (2020)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Salvi, Sundeep S, et al.
Publicado: (2016)

Minoxidil Topical Foam: A New Kid on the Block
por: Gogtay, Jaideep A, et al.
Publicado: (2009)

Research, residents, and registrars – getting it right
por: Saha, Shruti, et al.
Publicado: (2022)

Determination of reference intervals from a laboratory database of an academic clinical research unit in a tertiary care teaching hospital and an audit of out of range values
por: Figer, Brinal H., et al.
Publicado: (2021)

Remdésivir chez les patients hospitalisés pour la COVID-19 au Canada: essai clinique randomisé et contrôlé
Publicado: (2022)

Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
por: Buxeda, Anna, et al.
Publicado: (2021)

Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
por: Butt, Batool, et al.
Publicado: (2022)

Clinical Effectiveness and Safety of Remdesivir in Hemodialysis Patients with COVID-19
por: Lim, Jeong-Hoon, et al.
Publicado: (2022)

Understanding perception of chronic obstructive pulmonary disease among general practitioners, physicians, and pulmonologists in India: Results from a face-to-face survey
por: Kaur, Ishpreet, et al.
Publicado: (2016)

Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population
por: Rajan, Sujeet K., et al.
Publicado: (2014)

Preference of diagnostic tools, medications, and devices for asthma management: A survey of doctors in Algeria
por: Gogtay, Jaideep, et al.
Publicado: (2019)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Comparative Safety and Efficacy of Remdesivir Versus Remdesivir Plus Convalescent Plasma Therapy (CPT) and the Effect of Timing of Initiation of Remdesivir in COVID-19 Patients: An Observational Study From North East India
por: Sharma, Dibya J, et al.
Publicado: (2021)

Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats
por: Pattanashetti, Laxmi Adiveppa, et al.
Publicado: (2017)

COVID-19: what is not being addressed
por: Gupte, Jaideep, et al.
Publicado: (2021)

Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study
por: Khalil, Ahmed, et al.
Publicado: (2023)

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48omcv5d48qgcd44k6lh72gja8